The knockout cells showed remarkable resistance to both Ara‐C and clofarabine but not to VCR and DNR, demonstrating that DCK activity is specifically indispensable for the antileukemic activities of Ara‐C and clofarabine in BCP‐ALL. The gene discussed is DCK; the disease is acute lymphoblastic leukemia.